| Literature DB >> 27080848 |
Jean-Louis Montastruc1, Emmanuelle Bondon-Guitton2, Delphine Abadie2, Isabelle Lacroix2, Aurélia Berreni2, Grégory Pugnet3, Geneviève Durrieu2, Laurent Sailler3, Jean-Paul Giroud4, Christine Damase-Michel2, François Montastruc2.
Abstract
Self-medication means resorting to one or more drugs in order to treat oneself without the help of a doctor. This phenomenon is developing fast. In this review, we will discuss the main definitions of self-medication; we will then present a few important characteristics of this therapeutic practice: prevalence, reasons, populations involved and drugs used. Whilst the theoretical risks of self-medication have been abundantly discussed in the literature (adverse effects, interactions, product, dosage or treatment duration errors, difficulty in self-diagnosis, risk of addiction or abuse…), there is in fact very little detailed pharmacovigilance data concerning the characteristics and the consequences of this usage in real life. This study therefore describes the all too rare data that is available: patients, clinical characteristics, "seriousness" and drugs involved in the adverse effects of self-medication. It also discusses leads to be followed in order to minimize medication risks, which are obviously not well known and clearly not sufficiently notified.Entities:
Keywords: Benzodiazepines; Medical adverse effects; Non-steroid anti-inflammatory drugs; Painkillers; Pharmacovigilance; Risks; Self-medication
Mesh:
Year: 2016 PMID: 27080848 DOI: 10.1016/j.therap.2016.02.012
Source DB: PubMed Journal: Therapie ISSN: 0040-5957 Impact factor: 2.070